These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 9285602

  • 1. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.
    Lasner TM, Weil RJ, Riina HA, King JT, Zager EL, Raps EC, Flamm ES.
    J Neurosurg; 1997 Sep; 87(3):381-4. PubMed ID: 9285602
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    McGirt MJ, Mavropoulos JC, McGirt LY, Alexander MJ, Friedman AH, Laskowitz DT, Lynch JR.
    J Neurosurg; 2003 Jun; 98(6):1222-6. PubMed ID: 12816268
    [Abstract] [Full Text] [Related]

  • 4. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage.
    Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, Hepner H, Picard L, Laxenaire MC.
    Stroke; 1999 Jul; 30(7):1402-8. PubMed ID: 10390314
    [Abstract] [Full Text] [Related]

  • 5. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study.
    Weir BK, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigrest A.
    J Neurosurg; 1998 Sep; 89(3):405-11. PubMed ID: 9724114
    [Abstract] [Full Text] [Related]

  • 6. Subarachnoid hemorrhage on computed tomography scanning and the development of cerebral vasospasm: the Fisher grade revisited.
    Smith ML, Abrahams JM, Chandela S, Smith MJ, Hurst RW, Le Roux PD.
    Surg Neurol; 2005 Mar; 63(3):229-34; discussion 234-5. PubMed ID: 15734507
    [Abstract] [Full Text] [Related]

  • 7. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
    Murayama Y, Malisch T, Guglielmi G, Mawad ME, Viñuela F, Duckwiler GR, Gobin YP, Klucznick RP, Martin NA, Frazee J.
    J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.
    Seiler RW, Grolimund P, Zurbruegg HR.
    Acta Neurochir (Wien); 1987 Dec; 85(1-2):7-16. PubMed ID: 2955675
    [Abstract] [Full Text] [Related]

  • 9. [Symptomatic vasospasm after subarachnoid hemorrhage: study of 186 cases].
    Liu WG, Yang XF, Cao F, Zheng XJ, Shen H, Fu WM, Lü ST.
    Zhonghua Yi Xue Za Zhi; 2006 Apr 18; 86(15):1040-3. PubMed ID: 16784707
    [Abstract] [Full Text] [Related]

  • 10. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.
    McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE.
    J Neurosurg; 2007 Dec 18; 107(6):1080-5. PubMed ID: 18077943
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk factors associated with cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Inagawa T, Yahara K, Ohbayashi N.
    Neurol Med Chir (Tokyo); 2014 Jun 17; 54(6):465-73. PubMed ID: 24670311
    [Abstract] [Full Text] [Related]

  • 13. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC, Kassell NF, Torner JC.
    J Neurosurg; 1993 Apr 17; 78(4):537-47. PubMed ID: 8450326
    [Abstract] [Full Text] [Related]

  • 14. Effects of tobacco dose and length of exposure on delayed neurological deterioration and overall clinical outcome after aneurysmal subarachnoid hemorrhage.
    Krishnamurthy S, Kelleher JP, Lehman EB, Cockroft KM.
    Neurosurgery; 2007 Sep 17; 61(3):475-80; discussion 480-1. PubMed ID: 17881958
    [Abstract] [Full Text] [Related]

  • 15. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB.
    J Neurosurg; 1991 Aug 17; 75(2):189-96. PubMed ID: 1906534
    [Abstract] [Full Text] [Related]

  • 16. Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage.
    Howington JU, Kutz SC, Wilding GE, Awasthi D.
    J Neurosurg; 2003 Aug 17; 99(2):271-5. PubMed ID: 12924699
    [Abstract] [Full Text] [Related]

  • 17. Treatment modality and vasospasm after aneurysmal subarachnoid hemorrhage.
    Gross BA, Rosalind Lai PM, Frerichs KU, Du R.
    World Neurosurg; 2014 Dec 17; 82(6):e725-30. PubMed ID: 23954735
    [Abstract] [Full Text] [Related]

  • 18. Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period.
    Säveland H, Hillman J, Brandt L, Edner G, Jakobsson KE, Algers G.
    J Neurosurg; 1992 May 17; 76(5):729-34. PubMed ID: 1564533
    [Abstract] [Full Text] [Related]

  • 19. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.
    Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM.
    J Neurosurg; 2002 Mar 17; 96(3):510-4. PubMed ID: 11883835
    [Abstract] [Full Text] [Related]

  • 20. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D, Eicker S, Beseoglu K, Behr J, Turowski B, Steiger HJ.
    Cent Eur Neurosurg; 2009 May 17; 70(2):61-7. PubMed ID: 19711257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.